In addition, functionalized nanoparticles tagged with ligands, antibodies, or peptides selectively recognize melanoma-specific markers such as glycoprotein 100 (gp100) and melanoma cell adhesion molecule (MCAM), thereby promoting drug accumulation in tumor tissue while minimizing systemic toxicity. This evidence concerns the gene PMEL and neoplasm.